Literature DB >> 18089486

Recommendations for the reporting of prostate carcinoma: Association of Directors of Anatomic and Surgical Pathology.

Jonathan I Epstein1, John Srigley, David Grignon, Peter Humphrey.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18089486     DOI： 10.1309/59U8R6N5R7BKCWLV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN： 0002-9173            Impact factor:   2.493


× No keyword cloud information.
  12 in total

1.  Molecular sampling of prostate cancer: a dilemma for predicting disease progression.

Authors:  Andrea Sboner; Francesca Demichelis; Stefano Calza; Yudi Pawitan; Sunita R Setlur; Yujin Hoshida; Sven Perner; Hans-Olov Adami; Katja Fall; Lorelei A Mucci; Philip W Kantoff; Meir Stampfer; Swen-Olof Andersson; Eberhard Varenhorst; Jan-Erik Johansson; Mark B Gerstein; Todd R Golub; Mark A Rubin; Ove Andrén
Journal:  BMC Med Genomics       Date:  2010-03-16       Impact factor: 3.063

Review 2.  Isolated, disseminated and circulating tumour cells in prostate cancer.

Authors:  David Schilling; Tilman Todenhöfer; Jörg Hennenlotter; Christian Schwentner; Tanja Fehm; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2012-07-10       Impact factor: 14.432

Review 3.  What is the pathologist saying? Interpretation of the prostate pathology report.

Authors:  Omar Hameed
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

4.  Do robotic prostatectomy positive surgical margins occur in the same location as extraprostatic extension?

Authors:  Matthew T Johnson; Mitchell L Ramsey; Joshua J Ebel; Ronney Abaza; Debra L Zynger
Journal:  World J Urol       Date:  2013-10-06       Impact factor: 4.226

5.  Vas deferens invasion: A neglected issue in the sampling of radical prostatectomy materials.

Authors:  Nuri Yigit; Yildirim Karslioglu; Bulent Kurt
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

6.  Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.

Authors:  Steven N Seyedin; Darrion L Mitchell; Sarah L Mott; J Kyle Russo; Chad R Tracy; Anthony N Snow; Jessica R Parkhurst; Mark C Smith; John M Buatti; John M Watkins
Journal:  Pathol Oncol Res       Date:  2017-10-27       Impact factor: 3.201

7.  Beyond diagnosis: evolving prostate biopsy in the era of focal therapy.

Authors:  J L Dominguez-Escrig; S R C McCracken; D Greene
Journal:  Prostate Cancer       Date:  2010-12-09

8.  Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia.

Authors:  Donghyun Lee; Chunwoo Lee; Taekmin Kwon; Dalsan You; In Gab Jeong; Jun Hyuk Hong; Hanjong Ahn; Choung-Soo Kim
Journal:  Korean J Urol       Date:  2015-07-24

9.  ERG Immunohistochemistry as an Endothelial Marker for Assessing Lymphovascular Invasion.

Authors:  Sehun Kim; Hyung Kyu Park; Ho Young Jung; So-Young Lee; Kyueng-Whan Min; Wook Youn Kim; Hye Seung Han; Wan Seop Kim; Tae Sook Hwang; So Dug Lim
Journal:  Korean J Pathol       Date:  2013-08-26

10.  CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.

Authors:  Okyaz Eminaga; Mahmoud Abbas; Reemt Hinkelammert; Ulf Titze; Olaf Bettendorf; Elke Eltze; Enver Ozgür; Axel Semjonow
Journal:  BMC Med Inform Decis Mak       Date:  2012-12-03       Impact factor: 2.796
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.